REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 131 filers reported holding REVOLUTION MEDICINES INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,057,012 | +3.5% | 74,314 | +0.0% | 0.01% | +20.0% |
| Q2 2023 | $1,987,525 | -11.6% | 74,300 | -28.4% | 0.01% | -16.7% |
| Q1 2023 | $2,247,442 | +246.9% | 103,760 | +281.5% | 0.01% | +200.0% |
| Q4 2022 | $647,904 | -76.3% | 27,200 | -80.4% | 0.00% | -77.8% |
| Q3 2022 | $2,730,000 | +157.1% | 138,454 | +154.0% | 0.01% | +125.0% |
| Q2 2022 | $1,062,000 | -70.5% | 54,504 | -61.3% | 0.00% | -63.6% |
| Q1 2022 | $3,594,000 | +12.0% | 140,881 | +10.5% | 0.01% | +57.1% |
| Q4 2021 | $3,208,000 | +2.8% | 127,445 | +12.4% | 0.01% | 0.0% |
| Q3 2021 | $3,121,000 | -19.3% | 113,434 | -6.9% | 0.01% | -22.2% |
| Q2 2021 | $3,866,000 | +310.4% | 121,806 | +493.2% | 0.01% | +350.0% |
| Q1 2021 | $942,000 | – | 20,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |